- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. II.
-
- MORITA IWAO
- Research Laboratories, Nippon Shinyaku Co., Ltd.
-
- KUNIMOTO KATSUTOSHI
- Research Laboratories, Nippon Shinyaku Co., Ltd.
-
- TSUDA MASAMI
- Research Laboratories, Nippon Shinyaku Co., Ltd.
-
- TADA SHIN-ICHI
- Research Laboratories, Nippon Shinyaku Co., Ltd.
-
- KISE MASAHIRO
- Research Laboratories, Nippon Shinyaku Co., Ltd.
-
- KIMURA KIYOSHI
- Research Laboratories, Nippon Shinyaku Co., Ltd.
Search this article
Description
A series of 1, 4-dihydropyridine-5-cyclic phosphonate derivatives, designed as analogues of 1, 4- dihydropyridine-3, 5-dicarboxylate calcium antagonists, was synthesized and examined for antihypertensive activity. Several compounds were proved to have activities superior or comparable to that of nifedipine in lowering blood pressure in normotensive and spontaneously hypertensive rats (SHR). Among these compounds, methyl 2, 6-dimethyl-5- (2-oxo-1, 3, 2-dioxaphosphorinan-2-yl) -4- (2-nitrophenyl) -1, 4-dihydropyridine-3-carboxylate (31, DHP-218) was approximately 7 times more active than nifedipine in SHR and was selected for further development and clinical evaluation. The structure-activity relationships are discussed.
Journal
-
- Chemical and Pharmaceutical Bulletin
-
Chemical and Pharmaceutical Bulletin 35 (10), 4144-4154, 1987
The Pharmaceutical Society of Japan